Remedium Bio reported raising $10 Million in an initial SEC Form D filing, from an offering of $10 Million
Round Type
Series A
BostonBiotechnologyHealth CareTherapeuticsInvestors
Description
Remedium Bio, a biotechnology firm based in Needham, MA, has secured $10M in initial Series A funding. The financing round was led by Lifespan Vision Ventures, with contributions from Eli Lilly and Company and HKX Capital. Proceeds will be used to enhance its gene therapy platform and prepare for its first clinical studies. The company is focused on developing innovative therapies to address unmet medical needs.
Quick answer
Remedium Bio raised $10 Million in a Series A round, dated May 6, 2026. Investors: Eli Lilly And Company, HKX Capital and Lifespan Vision Ventures. Remedium Bio is based in Boston, Massachusetts, United States.
- How much did Remedium Bio raise?
- Remedium Bio raised $10 Million in a Series A round on May 6, 2026.
- Who invested in Remedium Bio?
- Eli Lilly And Company, HKX Capital and Lifespan Vision Ventures are named as investors in this round.
- What does Remedium Bio do?
- Remedium Bio is a gene therapy company focused on the development of treatments for large unmet clinical needs.
- Where is Remedium Bio based and how big is it?
- Remedium Bio is based in Boston, Massachusetts, United States.
- Who are the decision-makers at Remedium Bio?
- Fundz holds 1 contact at Remedium Bio. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as Remedium Bio that raised within 45 days of this round, from Fundz verified event records.
- Vedana raised $46M (Series A) on June 17, 2026.
- Aplagon raised $5.6M (Funding Round) on June 17, 2026.
- Racura Oncology raised $34M (Funding Round) on June 17, 2026.
- Vedana Therapeutics raised $46M (Series A) on June 17, 2026.
- Emmecell raised an undisclosed amount (Funding Round) on June 16, 2026.
- SpliSense raised $13M (Funding Round) on June 16, 2026.
Who to call at Remedium Bio, and when
A new round usually means Remedium Bio is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Remedium Bio raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Remedium Bio, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Remedium Bio. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Remedium Bio raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansRemedium Bio raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.